Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 4
2003 1
2004 2
2005 1
2006 4
2007 2
2008 2
2009 2
2010 1
2011 1
2012 2
2013 4
2014 3
2015 2
2016 3
2017 1
2018 3
2019 3
2020 4
2021 5
2022 8
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Systematic review of progressive familial intrahepatic cholestasis.
Baker A, Kerkar N, Todorova L, Kamath BM, Houwen RHJ. Baker A, et al. Clin Res Hepatol Gastroenterol. 2019 Feb;43(1):20-36. doi: 10.1016/j.clinre.2018.07.010. Epub 2018 Sep 17. Clin Res Hepatol Gastroenterol. 2019. PMID: 30236549 Free article.
Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study.
Gonzales E, Hardikar W, Stormon M, Baker A, Hierro L, Gliwicz D, Lacaille F, Lachaux A, Sturm E, Setchell KDR, Kennedy C, Dorenbaum A, Steinmetz J, Desai NK, Wardle AJ, Garner W, Vig P, Jaecklin T, Sokal EM, Jacquemin E. Gonzales E, et al. Among authors: baker a. Lancet. 2021 Oct 30;398(10311):1581-1592. doi: 10.1016/S0140-6736(21)01256-3. Epub 2021 Oct 28. Lancet. 2021. PMID: 34755627 Clinical Trial.
Impact of long-term administration of maralixibat on children with cholestasis secondary to Alagille syndrome.
Shneider BL, Spino CA, Kamath BM, Magee JC, Ignacio RV, Huang S, Horslen SP, Molleston JP, Miethke AG, Kohli R, Leung DH, Jensen MK, Loomes KM, Karpen SJ, Mack C, Rosenthal P, Squires RH, Baker A, Rajwal S, Kelly D, Sokol RJ, Thompson RJ; for ChiLDReN and UK IMAGO/IMAGINE Investigators. Shneider BL, et al. Among authors: baker a. Hepatol Commun. 2022 Aug;6(8):1922-1933. doi: 10.1002/hep4.1992. Epub 2022 Jun 7. Hepatol Commun. 2022. PMID: 35672955 Free PMC article.
Unacceptable failures: the final report of the Lancet Commission into liver disease in the UK.
Williams R, Aithal G, Alexander GJ, Allison M, Armstrong I, Aspinall R, Baker A, Batterham R, Brown K, Burton R, Cramp ME, Day N, Dhawan A, Drummond C, Ferguson J, Foster G, Gilmore I, Greenberg J, Henn C, Jarvis H, Kelly D, Mathews M, McCloud A, MacGilchrist A, McKee M, Moriarty K, Morling J, Newsome P, Rice P, Roberts S, Rutter H, Samyn M, Severi K, Sheron N, Thorburn D, Verne J, Vohra J, Williams J, Yeoman A. Williams R, et al. Among authors: baker a. Lancet. 2020 Jan 18;395(10219):226-239. doi: 10.1016/S0140-6736(19)32908-3. Epub 2019 Nov 29. Lancet. 2020. PMID: 31791690 Review.
Cardiac-associated biliary atresia (CABA): a prognostic subgroup.
Aldeiri B, Giamouris V, Pushparajah K, Miller O, Baker A, Davenport M. Aldeiri B, et al. Among authors: baker a. Arch Dis Child. 2021 Jan;106(1):68-72. doi: 10.1136/archdischild-2020-319122. Epub 2020 Jul 20. Arch Dis Child. 2021. PMID: 32690577
Pediatric endoscopy training across Europe: a survey of the ESPGHAN National Societies Network 2016-2019.
Papadopoulou A, Ribes-Koninckx C, Baker A, Noni M, Koutri E, Karagianni MV, Protheroe S, Guarino A, Mas E, Wilschanski M, Roman E, Escher J, Furlano RI, Posovszky C, Hoffman I, Bronsky J, Hauer AC, Tjesic-Drinkovic D, Fotoulaki M, Orel R, Urbonas V, Kansu A, Georgieva M, Thomson M. Papadopoulou A, et al. Among authors: baker a. Endosc Int Open. 2022 Oct 17;10(10):E1371-E1379. doi: 10.1055/a-1898-1364. eCollection 2022 Oct. Endosc Int Open. 2022. PMID: 36262519 Free PMC article.
53 results